Prognostic value of CD34 expression status in patients with myxofibrosarcomas and undifferentiated pleomorphic sarcomas
Yoshiya Sugiura(Japanese Foundation For Cancer Research), Kengo Takeuchi(Japanese Foundation For Cancer Research), Hiroaki Kanda(Saitama Cancer Center), Keisuke Ae(The Cancer Institute Hospital), Rikuo Machinami, Yutaka Takazawa(The Cancer Institute Hospital), Seiichi Matsumoto(Fukuda Denshi (Japan))
Cited by 11
Related Papers
Clear Cell Sarcoma of Soft Tissue
|The American Journal of Surgical Pathology|2008|283
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
|Proceedings of the National Academy of Sciences|2018|264
Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases
|International Journal of Radiation Oncology*Biology*Physics|2016|182
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
|Nature Communications|2019|137
Runx1 and Runx2 cooperate during sternal morphogenesis
|Development|2010|94